These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1078 related items for PubMed ID: 17885055

  • 1. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [Abstract] [Full Text] [Related]

  • 2. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
    Sung YS, Kwon HJ, Park BW, Cho G, Lee CK, Cho KS, Kim JK.
    AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH, Lee JM, Park JH, Kim SC, Joo I, Han JK, Choi BI.
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.
    Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van De Kaa CA, de la Rosette JJ, Blickman JG, Barentsz JO.
    Radiology; 2003 Oct; 229(1):248-54. PubMed ID: 12944607
    [Abstract] [Full Text] [Related]

  • 11. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE, Falkner F, Martirosian P, Schraml C, Schwentner C, Nickel D, Nikolaou K, Notohamiprodjo M.
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of pancreatic cancer by multiple breath-hold dynamic contrast-enhanced magnetic resonance imaging at 3.0T.
    Yao X, Zeng M, Wang H, Sun F, Rao S, Ji Y.
    Eur J Radiol; 2012 Aug; 81(8):e917-22. PubMed ID: 22695786
    [Abstract] [Full Text] [Related]

  • 13. Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate.
    Hansford BG, Karademir I, Peng Y, Jiang Y, Karczmar G, Thomas S, Yousuf A, Antic T, Eggener S, Oto A.
    Acad Radiol; 2014 May; 21(5):569-77. PubMed ID: 24703469
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors.
    Kitamoto E, Chikui T, Kawano S, Ohga M, Kobayashi K, Matsuo Y, Yoshiura T, Obara M, Honda H, Yoshiura K.
    Acad Radiol; 2015 Feb; 22(2):210-6. PubMed ID: 25442795
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
    Akisik MF, Sandrasegaran K, Bu G, Lin C, Hutchins GD, Chiorean EG.
    Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.